These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 14678910)

  • 1. [Clinical analysis of the relationship between injury of the marginal division and cognitive impairment].
    Wen ZB; Shu SY; Bao XM; Wu YM; Hang FH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1344-6. PubMed ID: 14678910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and diffuse white matter atrophy in alcoholics.
    Mochizuki H; Masaki T; Matsushita S; Ugawa Y; Kamakura K; Arai H; Motoyoshi K; Higuchi S
    Clin Neurophysiol; 2005 Jan; 116(1):223-8. PubMed ID: 15589200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relating one-year cognitive change in mild cognitive impairment to baseline MRI features.
    Duchesne S; Caroli A; Geroldi C; Collins DL; Frisoni GB
    Neuroimage; 2009 Oct; 47(4):1363-70. PubMed ID: 19371783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Saka E; Dogan EA; Topcuoglu MA; Senol U; Balkan S
    Arch Gerontol Geriatr; 2007; 44(2):141-51. PubMed ID: 16723158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment.
    Cipriani G; Bianchetti A; Trabucchi M
    Arch Gerontol Geriatr; 2006; 43(3):327-35. PubMed ID: 16451811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.
    Almkvist O; Tallberg IM
    Neuropsychology; 2009 Jan; 23(1):117-24. PubMed ID: 19210039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
    Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning in patients with cerebral aneurysms measured with the mini mental state examination and the telephone interview for cognitive status.
    King JT; DiLuna ML; Cicchetti DV; Tsevat J; Roberts MS
    Neurosurgery; 2006 Oct; 59(4):803-10; discussion 810-1. PubMed ID: 17038944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    Koga H; Takashima Y; Murakawa R; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):32-7. PubMed ID: 19110142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.